#mwc15health florence perkins alcatel lucent ict & pharma partnerships are key for mhealth
TRANSCRIPT
lCT & Pharma partnerships are key for mHealthHealth & Wellness-Mobile World Congress
March 3, 2015Florence Gaudry-Perkins- International Director Global Government & Public Affairs
Source: MedCityNews.com
ALCATEL-LUCENT’S INVOLVEMENT in mHealth
A SOCIAL INNOVATION INITIATIVE
Creating Shared Value
Partner of the mDiabetes project in Senegal
¾Part of the “Be He@lthy Be Mobile” ITU and WHO initiative
¾Goal: use mobile technology and mHealth to fight diabetes
¾SMS and applications will address the following: •mAwereness: Help diagnose patients (50% to 90% are undiagnosed in Africa)•mEducation: educate diabetics to prevent the disease and better manage it (goal for ex to reduceamputations by 50% over the next 4 years)•mTraining: Educate health workers•mTracking/mDiagnosis: Develop tools for remote diagnosis (ex pictures of foot wounds sent by smart phones)
¾ Launch of mRamadan pilot in Dakar June 16th. Official launch of project in November 2014 around International Diabetes Day. 4-year project to grow incrementally- Over 1 million SMS & Quizzes planned for next 10 months.
¾Alcatel-Lucent contributes with : SaaS platform, Helps Ministry of Health in coordination and fostering links with the ICT partners & ecosystem, links with funding institutions, work on financial sustainability & business models. Now integrating eGovt approach and assisting in overall eHealth approach for Senegal
Fighting the global health burden through new
technology…
WHO-ITU joint program on mHealth for NCDs
A Cross-Sectoral & Multi-Stakeholder Model
THE PROGRAM IS UNIQUE IN THAT IT ADOPTS A MULTI SECTOR PARTNERSHIP STRUCTURE AND ENGAGES IN COUNTRY PARTNERS AND GOVERNMENTS TO MAXIMIZE SUCCESS.
Telecoms, Insurance ,
Pharma, Wellness, IT, Sporting
Industry, Other Private Sector
Government
NGOs , Civil Society
PhilanthropiesAcademia
UN
• Best Practices• Content• Deployment strategy• M&E
• Best Practices• Content• Technology• Deployment strategy• Policies• M&E
• Best Practices• Content• Technology• Deployment strategy• Policies• M&E
• Best Practices• Content• Technology• Deployment strategy• M&E
Source: ITU-WHO
Launch of mDiabetes pilot in Senegal around Ramadan in June 2014
3500 Diabetic patients received a total of 80 000 messages before and during Ramadan to prevent the problems due to fasting
« It is soon Ramadan! Consult you Doctor to verify if yourglucose level is normal, ie. between 0,90 and 1, 20 g/l). More info on www.mdiabete.gouv.sn
« Attention! If you are following an insulin treatment it ispreferable to avoid fasting. More info on www.mdiabet.gouv.sn»
« Re-adapt your medication doses and hours with yourDoctor before starting your fast ».
« Drink approximately one liter of water in the morningbefore staring your day of fasting »
“Attention! If you have heart, kidney or eye complications, you should avoid fasting”.
Role of Pharma in mHealth
7
Digital Health & Trend of Moving Beyond the Pill for Pharmas
¾Pharma companies must move from a "selling the pill" model to truly integrated patient care. Will lower costs of innovation and trigger new business opportunities.
¾Mobile health is instrumental in the movement toward more patient-centric healthcare
¾Big data is a big opportunity for pharmas. It will ease discovery of new medicines and open new avenues for improved patient care (personalized medicine, faster, safer and less expensive clinical trials and innovations)*
¾There is a real systemwide refocusing on health outcomes improvementwhich pharmas must be part of
*McKinsey estimated that just the U.S. healthcare system could save $300 billion a year through the
better integration and analysis of health data.
Source: MobileHealthNews
Source:http://www.clinicalleader.com/doc/mh1
A few examples of revenue generating potential for pharmas
•New products and services: Ex WellDoc solution is mobile coaching solution for diabetes patients. Now FDA approved reimbursed by health insurances at up to $50-$100/month. Other ex could be: ingestible or wearable sensors, connectedDevices etc.
•Diagnosing the undiagnosed: ex 45,8% of cases of adult diabetes in the world are undiagnosed and 84% of them are located in low- and middle-income countries. Awareness mHealth campaigns could be a powerful tool to identify undiagnosed cases
•Adherence: The MediSafe app which sends SMS reminders showed a 81% adherence improvement for a treatment of type 2 diabetes. Non-adherence of treatments leads to a decrease of sales of 36% for pharma companies (& costs the health-system just in the US estimated at $290 billion annually)
•Supply Chain: ex SMS project in Mozambique decreased vaccine stock problems from 80% to 1%. Novartis, in partnership with Vodacom, has shown in Tanzania that SMS system ("TEXT for Life") reduced inventory issues on drugs for tuberculosis in rural centers from 79% to less than 26%.
•Improve Go-to-Market Strategies: mHealth requires collaborative work with patients, caregivers, insurers, patient associations, regulators and governments.
3 initiatives
IFPMA released a report in July 2013 where 37 mHealth programs from the Pharmaceutical industry are referenced
Source: IFPMA 2013
3 initiatives 4 initiatives
12 initiatives 4 initiatives 5 initiatives
4 initiatives 1 initiative 1 initiative
*
***
*
Pharma involvment on the rise
http://www.ifpma.org/fileadmin/content/Publication/2013/IFPMA_Health_at_your_fingertips_July2013.pdf
Pharma App Market Benchmarking released in October 2014- research2guidance
mHealth Challenges for pharma Industry
•Pharmas are not as trusted by patients as physicians
or even insurers
•Pharma companies are typically risk averse in large part due to development of drug programs being about managing risks
•Unclarity on ROI and business models•Lack of expertise in the area of digital • Big change of mindset needed: pharmas are organized around the solution being the product
•Regulatory challenges, Data Privacy, Interoperabilty & Standardization
•Lack of clinical evidence
•Lack of involvement from patients in the design of the apps
adapted from Flickr http://www.flickr.com/photos/clanlife/6369791755/Creative commons.org/licenses/by.2.0.deed.edu
Some recommendations
•Cross-sector partnerships between ICT sector & pharma are key!
•Don’t necessarily think only along traditional ways of branding •Set up innovation teams who can focus on LT opportunities
•Get governments onboard
• Allow innovation/incubation on the business models depending on the markets and the services
•Plan and implement Measurement & Evaluation
Source: MobileMarketingWatch
Eric J. Topol, M.D., cardiologist, geneticist, and researcherAuthor of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care”
“Medicine is about to go through its biggest shakeup in history”
Contact Alcatel-Lucent: Florence GAUDRY-PERKINS-International Director Global Government & Public [email protected]